Signant Acquires DSG

Article

Signant adds DSG’s solution suite to its own capabilities to grow CRO and sponsor services.

Signant Health has acquired DSG – a 20-year-old provider of electronic data capture (EDC) and direct data capture (DDC) technology for site-based and decentralized clinical trials. DSG will become a Signant company, and Signant will add the DSG capabilities to its digital solutions for clinical trials, including eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics.

The DSG solution suite was chosen based on the following criteria: (1) ease of use – where sites in particular provided positive feedback; (2) operational efficiency – combines rapid study start up times with workflow tools and remote SDV capabilities; (3) flexibility –accommodates the requirements of both simple and complex study designs; and (4) customer support.

“We believe DSG is the industry’s best kept secret. We are excited to welcome the DSG team to Signant, enabling us to extend our product suite to include comprehensive EDC/DDC capabilities,” said Roger Smith, Signant’s chief executive officer.

Reference: Signant Acquires DSG to Enhance Its eClinical Solution Suite for Traditional and Decentralized Clinical Trials. PHILADELPHIA, PA – July 17, 2023. https://www.signanthealth.com/company/newsroom/item/signant-acquires-dsg-to-enhance-its-eclinical-solution-suite-for-traditional-and-decentralized-clinical-trials/

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.